Oreola Donini
Technik-/Wissenschafts-/F&E-Leiter bei SOLIGENIX, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Oreola Donini
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SOLIGENIX, INC. | Technik-/Wissenschafts-/F&E-Leiter | 15.08.2013 | - |
Karriereverlauf von Oreola Donini
Ehemalige bekannte Positionen von Oreola Donini
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Inimex Pharmaceuticals, Inc.
 Inimex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inimex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of Innate Defense Regulators (IDRs). IDRs are novel drugs that selectively trigger the body's innate defenses, protecting against antibiotic-resistant infections and controlling inflammation. The company was founded in 2001 and is headquartered in Vancouver, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 | 01.01.2013 |
| ESSA PHARMA INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 | 01.01.2013 |
| Kinetek Pharmaceuticals, Inc. | Corporate Officer/Principal | - | - |
Ausbildung von Oreola Donini
| Queen's University | Doctorate Degree |
| The University of California, San Francisco | Graduate Degree |
Statistik
International
| Kanada | 5 |
| Vereinigte Staaten | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| ESSA PHARMA INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Inimex Pharmaceuticals, Inc.
Inimex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inimex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of Innate Defense Regulators (IDRs). IDRs are novel drugs that selectively trigger the body's innate defenses, protecting against antibiotic-resistant infections and controlling inflammation. The company was founded in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
| Kinetek Pharmaceuticals, Inc. | Health Technology |
- Börse
- Insiders
- Oreola Donini
- Erfahrung
